Ken Possenriede
Management
Okay. Hey, Rich, it's Ken. Hopefully, this will resonate with you, but I think it's a consistent story. First and foremost, we're going to generate as much cash as we can, and that was one of the rationales of why we decided to start deferring our ERISA funding in 2021 from an economic standpoint. That made the most sense. But first and foremost, we're going to invest in our business, whether that's organic or inorganically. We have still some decent-sized capital outlays this year of, rough numbers, about $1.8 billion. We're at record levels of IRAD spend this year, and we'll continue to do that. And we'll - this - again, we'll focus on organic. And then inorganically, in Jim's prepared statements, we talked about Aerojet Rocketdyne. That's on-track. We just got our second request from the FTC, which is no surprise. Nothing has changed. We're still very bullish about that for that to come to resolution in the fourth quarter of this year. And then it comes down to the excess cash, what do we do with it? We are focused on our dividend strategy. That would be the next in the batting order. We're going to - in the third quarter, Jim and I will go see the Board with our Treasurer, John Mallard, to make a recommendation on what's the appropriate increase in our dividends, and it should be deemed favorable to our shareholders. And then lastly, it's share buybacks. And frankly, Rich, what we saw in the first quarter where our stock was trading, we thought it was grossly undervalued, and we went into this accelerated share buyback plan and deemed to be very successful. And we will opportunistically, in the next three quarters, buy back stock where it makes sense. And think of that as anywhere from $500 million to $1 billion in the next three months. We have the balance sheet to do everything I just described, and we'll continue evaluating that. And I'll hand it over to Jim to talk about if there's any other investments in - I think you mentioned ABL and other type opportunities out there.